ProductUpdated on 5 May 2026
ADStem - canine stem cells for osteoarthritis
About
We are completing the submission of our Regulatory Dossier in Europe and the UK in 2026 and are looking to engage with prospective partners to bring our innovative treatments to the market, using our purpose built and certified GMP mass-production site.
We are interested in discussing partnerships in three areas:
-
investment to finance market entry/scaling
-
licencing our product for markets, primarily outside of the EU and UK
-
distributing our product in the EU and UK.
Looking for
- Distribution Partner
- Commercial Partner
- Strategic Partner
- Licensing Partner
- Investor
Applies to
- Animal Health Biotechnology
- Veterinary Therapeutics
Organisation
Sheffield, United Kingdom
Similar opportunities
Service
GMP manufacturing of cell-based products
- Research
- Consulting
- Development
- Manufacturing
- Regulatory Support
- Pharmaceutical R&D
- Testing & Validation
- Veterinary & Animal Health
- Biotechnology & Life Sciences
Endre Kiss-Toth
Founder, CEO at StemcellX Limited
Sheffield, United Kingdom
Product
A biological to treat pyoderma
- Investor
- Industry Partner
- Strategic Partner
- Licensing Partner
- Technology Partner
- Manufacturing Partner
- Veterinary Therapeutics
- Animal Health Biotechnology
- Antimicrobial Resistance Solutions
Sven ARNOUTS
Business Development Manager at Ghent University - provaxs
Merelbeke, Belgium
Product
A probiotic to improve udder health
- Industry Partner
- Strategic Partner
- Licensing Partner
- Livestock Farming
- Commercial Partner
- Technology Partner
- Veterinary Therapeutics
- Animal Health Biotechnology
- Sustainable Livestock Health
- Antimicrobial Resistance Solutions
Sven ARNOUTS
Business Development Manager at Ghent University - provaxs
Merelbeke, Belgium